SCHEMBL1236809

SCHEMBL1236809

CC(C)(c1cc(O)c2c(-c3ccccc3)coc2c1)C1CCCCC1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.43
SMN1; SMN2 Q16637 5/20 0.43
ALOX15 P16050 3/20 0.43
MEN1 O00255 3/20 0.43
TP53 P04637 3/20 0.43
CYP3A4 P08684 3/20 0.43
MAPT P10636 3/20 0.43
HPGD P15428 3/20 0.43
KMT2A Q03164 3/20 0.43
HSD17B10 Q99714 2/20 0.43
USP2 O75604 1/20 0.43
ALOX12 P18054 1/20 0.43
BRCA1 P38398 1/20 0.43
BLM P54132 1/20 0.43
SIRT1 Q96EB6 1/20 0.42
PSMB5 P28074 2/20 0.35
PSMB8 P28062 1/20 0.35
CNR1 P21554 3/20 0.35
CNR2 P34972 3/20 0.35
TSHR P16473 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1234944 0.85 SIRT1 (0.36) SIRT1CNR1CNR2ABL1EGFR
SCHEMBL1236041 0.82 CNR1 (0.33) ALDH1A1SMN1; SMN2MEN1TP53MAPT
SCHEMBL1236488 0.79 ALDH1A1 (0.50) ALDH1A1SMN1; SMN2ALOX15MEN1TP53
SCHEMBL1235883 0.78 ALDH1A1 (0.35) ALDH1A1SMN1; SMN2ALOX15MEN1TP53
SCHEMBL1236716 0.75 MAPT (0.41) ALDH1A1SMN1; SMN2ALOX15MEN1TP53
SCHEMBL1236224 0.72 CNR1 (0.43) ALDH1A1SMN1; SMN2ALOX15MEN1TP53
SCHEMBL1235919 0.71 CNR2 (0.51) CNR1CNR2
SCHEMBL1193258 0.71 ALDH1A1 (0.31) ALDH1A1SMN1; SMN2MEN1KMT2ACNR1
SCHEMBL1236879 0.71 CNR2 (0.63) ALDH1A1SMN1; SMN2ALOX15MEN1TP53
SCHEMBL1236078 0.70 ALDH1A1 (0.41) ALDH1A1SMN1; SMN2ALOX15MEN1TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8476309-B2 Benzofuran cannabinoid compounds and related methods of use THE UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION (US) 2013-07-02 US claimed
US-20110046175-A1 BENZOFURAN CANNABINOID COMPOUNDS AND RELATED METHODS OF USE THE UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION 2011-02-24 US claimed
WO-2011022679-A2 BENZOFURAN CANNABINOID COMPOUNDS AND RELATED METHODS OF USE UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION, THE (US) 2011-02-24 WO claimed
US-8476309-B2 Benzofuran cannabinoid compounds and related methods of use THE UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION (US) 2013-07-02 US disclosed
US-8476309-B2 Benzofuran cannabinoid compounds and related methods of use THE UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION (US) 2013-07-02 US disclosed
US-8476309-B2 Benzofuran cannabinoid compounds and related methods of use THE UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION (US) 2013-07-02 US disclosed
US-20110046175-A1 BENZOFURAN CANNABINOID COMPOUNDS AND RELATED METHODS OF USE THE UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION 2011-02-24 US disclosed
US-20110046175-A1 BENZOFURAN CANNABINOID COMPOUNDS AND RELATED METHODS OF USE THE UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION 2011-02-24 US disclosed
US-20110046175-A1 BENZOFURAN CANNABINOID COMPOUNDS AND RELATED METHODS OF USE THE UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION 2011-02-24 US disclosed
WO-2011022679-A2 BENZOFURAN CANNABINOID COMPOUNDS AND RELATED METHODS OF USE UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION, THE (US) 2011-02-24 WO disclosed
WO-2011022679-A2 BENZOFURAN CANNABINOID COMPOUNDS AND RELATED METHODS OF USE UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION, THE (US) 2011-02-24 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110046175-A1 BENZOFURAN CANNABINOID COMPOUNDS AND RELATED METHODS OF USE CNR1, CNR2, GPR18 ALDH1A1 576/4885SMN1; SMN2 3537/4885ALOX15 508/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.